サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1510695

アジア太平洋の心臓移植市場：2030年までの予測、地域別分析 - 手術の種類別、タイプ別、エンドユーザー別

Asia Pacific Heart Transplant Market Forecast to 2030 - Regional Analysis - by Surgery Type, Type, and End User

出版日
ページ情報
英文 70 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
アジア太平洋の心臓移植市場：2030年までの予測、地域別分析 - 手術の種類別、タイプ別、エンドユーザー別
出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 70 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の心臓移植市場は、2022年の34億2,568万米ドルから2030年には77億3,974万米ドルに成長すると予測されています。2022年から2030年までのCAGRは10.7%と推定されます。

高齢者人口の増加がアジア太平洋の心臓移植市場を押し上げる

高齢者人口はCVD、整形外科疾患、代謝疾患、神経疾患などに罹患しやすいです。WHOによると、世界の高齢化人口は2019年の10億人から2050年には21億人に増加すると見られています。中国とインドがそれぞれ10億人以上を占め、アジアの人口は2020年の時点で45億人を突破し、世界の総人口の半分以上を占めます。アジア人は4億1,400万人になると予測され、これは65歳以上のアメリカ人3億3,140万人を約20％上回ります。2050年には、アジアの高齢者人口は9億2,300万人を超えると予想されています。したがって、高齢者人口の増加と心不全の有病率の増加が心臓移植市場の成長を後押ししています。

アジア太平洋の心臓移植市場の概要

アジア太平洋地域の心臓移植市場は、中国、インド、日本、韓国、オーストラリア、その他アジア太平洋地域に区分されます。アジア太平洋地域は予測期間中、世界市場で最も速いCAGRを記録すると予想されます。この地域の市場成長は、臓器提供の重要性に対するヘルスケア意識の高まりと、臓器提供に対する前向きな姿勢を促すソーシャルメディアマーケティングの急増に起因しています。さらに、ヘルスケアインフラの進歩や製造能力を高めるための投資の増加が、予測期間中にアジア太平洋の心臓移植市場を牽引すると予測されています。BioMed Centralに掲載された記事によると、中国では死亡原因の40％以上がCVDに起因しています。また、2019年には、中国で約1億2,033万人がCVDに苦しんでいます。急速な社会経済の進歩は、中国の人々のライフスタイルに影響を与えており、その結果、心不全を引き起こす可能性のある心臓や血管の状態であるCVDに罹患する可能性が高まっています。現在のところ、心臓移植は進行した心不全に対する唯一の有効な治療法として知られています。しかし、心臓ドナーの数が限られているため、中国では年間わずか300例しか心臓移植が行われていません。そのため、心不全に苦しむ人々は、心臓移植の待機リストが長いため、人工心臓移植を選択しています。

アジア太平洋の心臓移植市場の収益と2030年までの予測

アジア太平洋の心臓移植市場のセグメンテーション

アジア太平洋の心臓移植市場は、手術の種類、タイプ、エンドユーザー、国別に区分されます。

手術の種類に基づき、アジア太平洋の心臓移植市場は同所性心臓移植と異所性心臓移植に二分されます。2022年のアジア太平洋心臓移植市場では、同所性心臓移植分野が大きなシェアを占めています。

タイプ別では、アジア太平洋の心臓移植市場はドナーライブ心臓と人工心臓に二分されます。2022年のアジア太平洋心臓移植市場では、ドナーライブ心臓分野が大きなシェアを占めています。さらに、人工心臓セグメントは心室補助装置と全人工心臓に分類されます。

エンドユーザーに基づき、アジア太平洋の心臓移植市場は病院、心臓センター、その他に区分されます。2022年のアジア太平洋の心臓移植市場では、病院セグメントが最大のシェアを占めています。

国別では、アジア太平洋の心臓移植市場は中国、インド、韓国、日本、オーストラリア、その他アジア太平洋地域に区分されます。中国が2022年のアジア太平洋心臓移植市場を独占しました。

Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、BiVACOR Inc、BioVentrix Inc、LivaNova Plcは、アジア太平洋の心臓移植市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の心臓移植市場 - 主要産業力学

  • 心臓移植市場：主要産業力学
  • 市場促進要因
    • 対象疾患の増加
    • 高齢者人口の増加
  • 市場抑制要因
    • 手術費用の高騰
  • 市場機会
    • ヘルスケア能力の向上と新興国における患者数の増加
  • 今後の動向
    • 移植手術におけるAIの活用
  • 促進要因と抑制要因の影響

第5章 心臓移植市場：アジア太平洋市場分析

  • 心臓移植市場の収益（2020年～2030年）
  • 心臓移植市場の予測と分析

第6章 アジア太平洋の心臓移植市場分析：手術の種類別

  • 同所性心臓移植
    • 同所性心臓移植市場、収益と2030年までの予測
  • 異所性心臓移植
    • 異所性心臓移植市場、収益と2030年までの予測

第7章 アジア太平洋の心臓移植市場分析：タイプ別

  • ドナーライブ心臓
    • ドナーライブ心臓市場、収益と2030年までの予測
  • 人工心臓
    • 人工心臓市場、収益と2030年までの予測
      • 心室補助デバイス
      • 全人工心臓

第8章 アジア太平洋の心臓移植市場分析：エンドユーザー編

  • 病院
    • 病院市場、収益と2030年までの予測
  • 心臓センター
    • 心臓センター市場、収益と2030年までの予測
  • その他
    • その他の市場、収益と2030年までの予測

第9章 アジア太平洋の心臓移植市場：国別分析

  • アジア太平洋
    • アジア太平洋の心臓移植市場概要
      • 中国
      • インド
      • 韓国
      • 日本
      • オーストラリア
      • アジア太平洋のその他諸国

第10章 業界情勢

  • 心臓移植市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Terumo Corp
  • Abbott Laboratories
  • Syn Cardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • LivaNova Plc

第12章 付録

図表

List Of Tables

  • Table 1. Heart Transplant Market Segmentation
  • Table 2. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
  • Table 3. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Surgery Type
  • Table 4. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Type
  • Table 5. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - End User
  • Table 6. Asia Pacific Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Country
  • Table 7. China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 8. China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 9. China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 10. China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 11. India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 12. India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 13. India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 14. India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 15. South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 16. South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 17. South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 18. South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 19. Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 20. Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 21. Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 22. Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 23. Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 24. Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 25. Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 26. Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 27. Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
  • Table 28. Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
  • Table 29. Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
  • Table 30. Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 31. Recent Inorganic Growth Strategies in the Heart Transplant Market
  • Table 32. Recent Organic Growth Strategies in the Heart Transplant Market

List Of Figures

  • Figure 1. Heart Transplant Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Heart Transplant Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Heart Transplant Market Share (%) - Surgery Type, 2022 and 2030
  • Figure 5. Orthotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Heterotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Heart Transplant Market Share (%) - Type, 2022 and 2030
  • Figure 8. Donor Live Heart Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Artificial Hearts Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Ventricular Assisted Device Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Total Artificial Heart Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Heart Transplant Market Share (%) - End User, 2022 and 2030
  • Figure 13. Hospitals Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Cardiac Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. Asia Pacific: Heart Transplant Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 17. Asia Pacific Heart Transplant Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 18. China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 19. India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 20. South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 21. Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 22. Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 23. Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 24. Growth Strategies in the Heart Transplant Market
目次
Product Code: BMIRE00030079

The Asia Pacific heart transplant market is expected to grow from US$ 3,425.68 million in 2022 to US$ 7,739.74 million by 2030. It is estimated to grow at a CAGR of 10.7% from 2022 to 2030.

Growing Geriatric Population Boosts Asia Pacific Heart Transplant Market

The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. With China and India accounting for more than one billion people each, Asia's population surpassed 4.5 billion as of 2020, making up more than half of the world's total population. Asians were predicted to number 414 million, which is around 20% more than the 331.4 million Americans who are 65 years of age or older. By 2050, it is expected that Asia will have over 923 million elderly population. Hence, the growing elderly population, along with the increasing prevalence of heart failure, fuels the heart transplant market growth.

Asia Pacific Heart Transplant Market Overview

The Asia Pacific heart transplant market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR in the global market during the forecast period. The market growth in this region is ascribed to the rise in healthcare awareness of the importance of organ donation and a surge in social media marketing to encourage a positive attitude toward organ donation. Additionally, advancing healthcare infrastructure and increasing investments to boost manufacturing capacities are projected to drive the Asia Pacific heart transplant market during the forecast period. According to an article published in BioMed Central, more than 40% of the deaths in China are attributed to CVDs. In addition, in 2019, about 120.33 million people suffered from CVDs in China. Rapid socioeconomic progress is impacting the lifestyle of the population in China, which, in turn, increases the chances of contracting CVDs, conditions of heart or blood vessels that may result in heart failure. At present, heart transplantation is the only well-known effective treatment for advanced heart failure. However, owing to the limited number of heart donors, only ~300 heart transplants are performed in China annually. Therefore, people suffering from heart failure opt for artificial heart transplants due to the long waiting list for heart transplantation.

Asia Pacific Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Heart Transplant Market Segmentation

The Asia Pacific heart transplant market is segmented into surgery type, type, end user, and country.

Based on surgery type, the Asia Pacific heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Asia Pacific heart transplant market in 2022.

In terms of type, the Asia Pacific heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Asia Pacific heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the Asia Pacific heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Asia Pacific heart transplant market in 2022.

Based on country, the Asia Pacific heart transplant market is segmented into China, India, South Korea, Japan, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific heart transplant market in 2022.

Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BiVACOR Inc, BioVentrix Inc, and LivaNova Plc are some of the leading companies operating in the Asia Pacific heart transplant market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Heart Transplant Market - Key Industry Dynamics

  • 4.1 Heart Transplant Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Target Disease Incidence
    • 4.2.2 Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgeries
  • 4.4 Market Opportunities
    • 4.4.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations
  • 4.5 Future Trends
    • 4.5.1 Use of AI in Transplantation Procedures
  • 4.6 Impact of Drivers and Restraints:

5. Heart Transplant Market - Asia Pacific Market Analysis

  • 5.1 Heart Transplant Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Heart Transplant Market Forecast and Analysis

6. Asia Pacific Heart Transplant Market Analysis - Surgery Type

  • 6.1 Overview
  • 6.2 Orthotopic Heart Transplant
    • 6.2.1 Overview
    • 6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Heterotopic Heart Transplant
    • 6.3.1 Overview
    • 6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Heart Transplant Market Analysis - Type

  • 7.1 Overview
  • 7.2 Donor Live Heart
    • 7.2.1 Overview
    • 7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Artificial Hearts
    • 7.3.1 Overview
    • 7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Ventricular Assisted Device
        • 7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.2 Total Artificial Heart
        • 7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Heart Transplant Market Analysis - End User

  • 8.1 Overview
  • 8.2 Hospitals
    • 8.2.1 Overview
    • 8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cardiac Centers
    • 8.3.1 Overview
    • 8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Heart Transplant Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia PacificHeart Transplant Market Overview
    • 9.1.2 Asia Pacific Heart Transplant Market Revenue and Forecasts and Analysis - By Country
      • 9.1.2.1 China: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.1 Overview
        • 9.1.2.1.2 China Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.1.3 China Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.1.4 China Heart Transplant Market Breakdown by Type
        • 9.1.2.1.4.1 China Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.1.5 China Heart Transplant Market Breakdown by End User
      • 9.1.2.2 India: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.1 Overview
        • 9.1.2.2.2 India Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.2.3 India Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.2.4 India Heart Transplant Market Breakdown by Type
        • 9.1.2.2.4.1 India Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.2.5 India Heart Transplant Market Breakdown by End User
      • 9.1.2.3 South Korea: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.1 Overview
        • 9.1.2.3.2 South Korea Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.3.3 South Korea Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.3.4 South Korea Heart Transplant Market Breakdown by Type
        • 9.1.2.3.4.1 South Korea Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.3.5 South Korea Heart Transplant Market Breakdown by End User
      • 9.1.2.4 Japan: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.4.1 Overview
        • 9.1.2.4.2 Japan Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.4.3 Japan Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.4.4 Japan Heart Transplant Market Breakdown by Type
        • 9.1.2.4.4.1 Japan Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.4.5 Japan Heart Transplant Market Breakdown by End User
      • 9.1.2.5 Australia: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.5.1 Overview
        • 9.1.2.5.2 Australia Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.5.3 Australia Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.5.4 Australia Heart Transplant Market Breakdown by Type
        • 9.1.2.5.4.1 Australia Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.5.5 Australia Heart Transplant Market Breakdown by End User
      • 9.1.2.6 Rest of APAC: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.6.1 Overview
        • 9.1.2.6.2 Rest of APAC Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
        • 9.1.2.6.3 Rest of APAC Heart Transplant Market Breakdown by Surgery Type
        • 9.1.2.6.4 Rest of APAC Heart Transplant Market Breakdown by Type
        • 9.1.2.6.4.1 Rest of APAC Heart Transplant Market Breakdown by Artificial Hearts
        • 9.1.2.6.5 Rest of APAC Heart Transplant Market Breakdown by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Heart Transplant Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Terumo Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Syn Cardia Systems LLC
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 BiVACOR Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 BioVentrix Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 LivaNova Plc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments

12. Appendix

  • 12.1 About the Insight Partners